Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Lanbo Biotechnology is a private Chinese manufacturer focused on niacinamide (nicotinamide), glycolic acid, and related biochemical, food additive, and feed additive products. The company appears to operate primarily as a commercial industrial biotech and specialty ingredient producer rather than a therapeutic drug developer. Public business descriptions emphasize R&D, production, and sales of feed-grade and skincare/cosmetic-grade niacinamide, along with other biochemical products. The company was founded in 1999 and is based in Haining, Jiaxing, Zhejiang, China. It was formerly listed on China\u2019s National Equities Exchange and Quotations system under the short name Lanbo Bio and code 836471, but later delisted while remaining an operating business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Lanbo Biotechnology.